Cheng, Yan https://orcid.org/0000-0001-7877-9622
Sun, Fumou https://orcid.org/0000-0003-2034-3492
Alapat, Daisy V.
Wanchai, Visanu https://orcid.org/0000-0003-2243-3838
Mery, David
Siegel, Eric R. https://orcid.org/0000-0001-9824-6612
Xu, Hongwei
Johnson, Sarah
Guo, Wancheng
Bailey, Clyde
Ashby, Cody https://orcid.org/0000-0002-9361-0283
Bauer, Michael Anton https://orcid.org/0000-0003-2498-7295
Hadidi, Samer Al https://orcid.org/0000-0003-4297-8042
Schinke, Carolina https://orcid.org/0000-0002-2699-1741
Thanendrarajan, Sharmilan
Zangari, Maurizio
van Rhee, Frits https://orcid.org/0000-0001-9959-1282
Tricot, Guido
Shaughnessy, John D. Jr
Zhan, Fenghuang https://orcid.org/0000-0001-5417-2973
Article History
Received: 11 July 2024
Revised: 10 October 2024
Accepted: 14 October 2024
First Online: 6 November 2024
Competing interests
: SAH reports receiving consulting fees from Jansen, Pfizer, and Sanofi.